Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury.
about
The role of atherectomy in the treatment of lower extremity peripheral artery diseaseNon-coding RNAs: the "dark matter" of cardiovascular pathophysiology.Developing miRNA therapeutics for cardiac repair in ischemic heart diseasemiR-92a inhibits vascular smooth muscle cell apoptosis: role of the MKK4-JNK pathwayPhenotypic characterization of miR-92a-/- mice reveals an important function of miR-92a in skeletal development.The association between circulating microRNA levels and coronary endothelial function.Use of statins in lower extremity artery disease: a review.MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts.Smooth muscle-specific drug targets for next-generation drug-eluting stentMechanisms and therapeutic potential of microRNAs in hypertension.MicroRNA Regulation of Atherosclerosis.Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure.Inhibition of MiR-92a May Protect Endothelial Cells After Acute Myocardial Infarction in Rats: Role of KLF2/4.Hepatic extracellular signal-regulated kinase 2 suppresses endoplasmic reticulum stress and protects from oxidative stress and endothelial dysfunctionFunction, Role, and Clinical Application of MicroRNAs in Vascular Aging.Roles of miR-17-92 Cluster in Cardiovascular Development and Common Diseases.Macro advances in microRNAs and myocardial regeneration.Novel potential targets for prevention of arterial restenosis: insights from the pre-clinical research.MicroRNA expression profiling of human blood monocyte subsets highlights functional differences.Exosomal miRNAs in Heart Disease.MicroRNAs as regulators of endothelial cell functions in cardiometabolic diseases.The multifactorial nature of microRNAs in vascular remodelling.Effects of shear stress on endothelial cells: go with the flow.Circulating Endothelial Cells Expressing the Angiogenic Transcription Factor Krüppel-Like Factor 4 are Decreased in Patients with Coronary Artery Disease.Stargazing microRNA maps a new miR-21 star for cardiac hypertrophy.Circulating miR-92a expression level in patients with essential hypertension: a potential marker of atherosclerosis.Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity.MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure.Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid Artery.Krüppel-like factor 4 regulates blood-tumor barrier permeability via ZO-1, occludin and claudin-5.Circulating microRNA profiles in different arterial territories of stable atherosclerotic disease: a systematic review.
P2860
Q27002637-4DC8F25C-4CE9-424C-A88B-986E4C044C38Q27693295-4FE1B9C7-3E68-45B3-A588-372C8D7A769FQ28077986-AD6F7E89-D69B-4B6E-802C-6CEDB1010969Q28505975-7ECCD89A-6B29-4EB0-9A3F-3E8CC0E4494FQ33825778-7CE1B107-8F35-4728-B5D4-06FA9207F174Q34332008-7BB9C4FB-A3FA-428D-B2A5-D64100779109Q34485974-115A6CA6-13D3-4BCE-B207-8C25B1B1F844Q34906347-1E93126B-D7B6-47C8-A8E4-12109326BF15Q35173060-6EDD6AC7-449C-4EDA-84A1-4112F11B8988Q36173562-41CF0E3D-67E4-411B-ADB3-52D87699FDF2Q36602813-8834DA97-EA93-4EDA-82E7-9255E65346D8Q36974257-2290B6A9-79C1-43AF-B60A-B947B870B26FQ37118803-3DE143C8-0F96-40D0-85E4-C83809E875BFQ37310401-752C10F2-1998-42DF-904A-DC3AB9111B66Q37554078-2CC53C0E-BD18-4D52-A79E-9544EDA817DDQ37601935-4E4B70A4-7A1A-456C-A956-97B6AB45CB44Q38195700-D58C67B3-5941-469E-8C80-05A25B76F3A1Q38235041-B3322BD2-73C5-4179-9FB3-5781B3C5B40DQ38466552-7A95E4E9-99AD-42B5-97DC-481CDC9D9D12Q38667736-D6179621-F322-4307-9816-A80F0B04B909Q38716293-893E66C5-1277-4DB8-80F5-3C1D39985D37Q38749173-BD3947E8-155A-4AE4-8146-4C521BC43A2BQ38849620-9FABAEF3-3225-4288-ACA3-01C6BEFAAFC5Q38980848-024B9646-C4CC-45B6-85A9-8F7D161A87D1Q38997582-12776C81-C280-43FD-A28B-010AA82B2412Q39389565-29DDF11D-FA9D-410B-A1E7-E6224AA32DBDQ40886790-62602FE6-9207-4959-BAC9-E1849A3D1A04Q42330259-B5FC4785-1EF0-43B5-BA98-5928941BF9EFQ48239504-5CE42C15-262B-4053-80E6-2E090E3A542DQ48819440-1764F8E5-C005-4A15-B977-1AF8E6446DA9Q55129172-58300E5A-2A7D-4F22-848A-C717190532B6
P2860
Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Inhibition of miR-92a increase ...... in vivo after vascular injury.
@en
Inhibition of miR-92a increase ...... in vivo after vascular injury.
@nl
type
label
Inhibition of miR-92a increase ...... in vivo after vascular injury.
@en
Inhibition of miR-92a increase ...... in vivo after vascular injury.
@nl
prefLabel
Inhibition of miR-92a increase ...... in vivo after vascular injury.
@en
Inhibition of miR-92a increase ...... in vivo after vascular injury.
@nl
P2093
P2860
P1476
Inhibition of miR-92a increase ...... in vivo after vascular injury.
@en
P2093
Alberto Polimeni
Antonio Curcio
Ciro Indolfi
Claudio Iaconetti
Gianluigi Pironti
Giovanni Esposito
Jolanda Sabatino
Sabato Sorrentino
P2860
P2888
P356
10.1007/S00395-012-0296-Y
P577
2012-08-14T00:00:00Z